Phathom Pharmaceuticals Inc (NASDAQ: PHAT) kicked off on Tuesday, up 4.59% from the previous trading day, before settling in for the closing price of $13.73. Over the past 52 weeks, PHAT has traded in a range of $2.21-$17.63.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 12.50%. While this was happening, its average annual earnings per share was recorded 40.34%. With a float of $40.20 million, this company’s outstanding shares have now reached $71.04 million.
Phathom Pharmaceuticals Inc (PHAT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Phathom Pharmaceuticals Inc is 43.49%, while institutional ownership is 48.15%. The most recent insider transaction that took place on Nov 03 ’25, was worth 7,079. In this transaction Principal Accounting Officer of this company sold 524 shares at a rate of $13.51, taking the stock ownership to the 47,407 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Principal Accounting Officer sold 461 for $12.09, making the entire transaction worth $5,573. This insider now owns 47,931 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.05 earnings per share (EPS), higher than consensus estimate (set at -1.08) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.34% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Take a look at Phathom Pharmaceuticals Inc’s (PHAT) current performance indicators. Last quarter, stock had a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -0.73 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
Compared to the last year’s volume of 1.61 million, its volume of 0.81 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 38.99%.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 79.69%, which indicates a significant increase from 54.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.98 in the past 14 days, which was higher than the 0.79 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.51, while its 200-day Moving Average is $8.22. Nevertheless, the first resistance level for the watch stands at $14.61 in the near term. At $14.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.26. If the price goes on to break the first support level at $13.96, it is likely to go to the next support level at $13.57. Now, if the price goes above the second support level, the third support stands at $13.31.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
The company with the Market Capitalisation of 1.02 billion has total of 71,138K Shares Outstanding. Its annual sales at the moment are 55,250 K in contrast with the sum of -334,330 K annual income. Company’s last quarter sales were recorded 49,500 K and last quarter income was -29,970 K.
